Italy authorizes Vortioxetina Zentiva antidepressant tablets
Italy's medicines agency AIFA has authorized Vortioxetina Zentiva, a generic version of the antidepressant vortioxetine, for sale in 5 mg and 10 mg tablets. The decision is dated 23 October 2026, and the license holder is Zentiva Italia S.r.l. of Milan. The tablets come in packs of 14, 28, 56 and 98, with the 98-tablet packs under a restricted prescription rule.
This summary was generated by AI; the official source prevails.
What does it mean?
Vortioxetine is a medicine used to treat depression. Patients in Italy can now get a version under the name Vortioxetina Zentiva, in 5 mg or 10 mg tablets. Most pack sizes need a normal prescription, while the 98-tablet packs need a restricted prescription.
Who is affected?
Patients with depression who are prescribed vortioxetine, along with their doctors and pharmacies in Italy.